NCT03068819View on ClinicalTrials.gov

Cytokine Induced Memory-like NK Cell Adoptive Therapy for Relapsed AML After Allogeneic Hematopoietic Cell Transplant

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 23, 2017

Primary Completion Date

June 15, 2025

Study Completion Date

June 15, 2025

Conditions

Acute Myeloid Leukemia

Interventions

DRUG

CIML NK Cell Infusion

-Day 0

PROCEDURE

CD3+ T Cell Product Infusion

-Day -1

Trial Locations (1)

63110

Washington University School of Medicine, St Louis

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

collaborator

Wugen, Inc.

INDUSTRY

collaborator

Children's Discovery Institute

OTHER

lead

Washington University School of Medicine

OTHER

NCT03068819 - Cytokine Induced Memory-like NK Cell Adoptive Therapy for Relapsed AML After Allogeneic Hematopoietic Cell Transplant | Biotech Hunter | Biotech Hunter